Albany, NY -- (SBWIRE) -- 09/05/2017 -- The competitive landscape of the global vitreous tamponades market is highly fragmented due to the presence of numerous local and global players, states Transparency Market Research (TMR). Some of the top players operating in the global vitreous tamponades market are Carl Zeiss Meditec AG, Alcon Inc., Fluron GmbH, Valeant Pharmaceuticals International Inc., and Dutch Ophthalmic Research Center B.V.

"Expansion of distribution networks and distributor subsidiaries is the strategy top companies in this market are adopting to augment sales," points out a TMR analyst. For example, Alchimia Srl's sales in the U.S. and Latin America are handled by Oftalmedia LLC, whereas its sales in other regions are handled by its Italy-based subsidiary BBS Srl.

View Full Report: http://www.transparencymarketresearch.com/vitreous-tamponades-market.html

The introduction of new products and new technologies is another key growth model that leading players in this market are exploring. Strategic mergers and acquisitions for the expansion of distributor base are on the growth plans of leading companies in the global vitreous tamponades market, adds TMR.

Declining Rate of Complications due to Diabetes in U.S. Challenges Market Growth

The major factor driving the global vitreous tamponades market is the increasing incidence of retinal detachment, macular pucker, and other ophthalmic conditions. Vitreous tamponades are used for the treatment of several vitreoretinal disorders such as retinal detachment, age-related macular degeneration, diabetic retinopathy, and vitreous hemorrhage. For instance, as per the International Diabetes Federation, almost 300 million individuals were affected with diabetes worldwide in 2010 and this number is expected to reach 438 million by 2030. A rising geriatric population that is susceptible to retinal disorders is also favoring the growth of the vitreous tamponades market.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4233

"The commoditization of the vitreous tamponades market in Asia Pacific, Europe, and Rest of the World is challenging the growth of this market", says a TMR analyst. Increasing demand for tamponades that are effective in the long-term and the price war that has spurred between local manufacturers and global vendors is adversely affecting industry revenue.

The decline in the incidence of diabetic retinopathy in North America is also slowing the growth of the global vitreous tamponades market. As per the American Diabetes Association, the complications arising due to diabetes have significantly reduced between 1990 and 2010 in the U.S. Moreover, the increasing number of awareness programs for routine eye examination carried out by governments and the World Health Organization has resulted in a considerable decline in the rate of proliferative diabetic retinopathy.

Request to download and view full ToC - Download Brochure link: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4233

Gaseous Tamponades to Display Significant Growth Rate in Future

Liquid tamponades dominated the global vitreous tamponades market on the basis of product type in 2013, the segment held more than 49% of the overall market in the same year. The large market share of liquid tamponades is attributed to their extensive use in Europe and Asia for the treatment of retinal detachments with multiple breaks, proliferative diabetic retinopathy, giant tears, and proliferative vitreoretinopathy. Silicone oil liquid tamponades will register the fastest growth during the report's forecast period. However, a high cost of silicone oil tamponades and their high chances of emulsification in the eye due to their low viscosity and surface tension are likely to limit the uptake of these tamponades. Perfluorocarbons liquid tamponades will display a constant growth rate as they are largely used for reattaching giant retinal tears.

On the other hand, gaseous tamponades will display the highest growth rate due to their low risk of emulsification, ease of use, and reduced cost.

Global Vitreous Tamponades Market Report is available @ US$ 5795

The global vitreous tamponades market is expected to reach a valuation of US$77.5 mn by 2020.

The information presented in this review is based on a Transparency Market Research study, titled, "Vitreous Tamponades Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020."

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/